Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Recent developments in bioprocessing of recombinant proteins: expression hosts and process development
NK Tripathi, A Shrivastava - Frontiers in Bioengineering and …, 2019 - frontiersin.org
Infectious diseases, along with cancers, are among the main causes of death among
humans worldwide. The production of therapeutic proteins for treating diseases at large …
humans worldwide. The production of therapeutic proteins for treating diseases at large …
Developments and opportunities in continuous biopharmaceutical manufacturing
O Khanal, AM Lenhoff - MAbs, 2021 - Taylor & Francis
Today's biologics manufacturing practices incur high costs to the drug makers, which can
contribute to high prices for patients. Timely investment in the development and …
contribute to high prices for patients. Timely investment in the development and …
Implementation of fully integrated continuous antibody processing: effects on productivity and COGm
L Arnold, K Lee, J Rucker‐Pezzini… - Biotechnology …, 2019 - Wiley Online Library
The changing landscape of the biopharmaceutical market is driving a paradigm shift toward
continuous manufacturing. To date, integrated continuous bioprocessing has not been …
continuous manufacturing. To date, integrated continuous bioprocessing has not been …
Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals
Biopharmaceuticals have emerged as powerful therapeutic agents, revolutionizing the
treatment landscape for various diseases, including cancer, infectious diseases …
treatment landscape for various diseases, including cancer, infectious diseases …
Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
Continuous integrated bioprocessing has elicited considerable interest from the biopharma
industry for the many purported benefits it promises. Today many major biopharma …
industry for the many purported benefits it promises. Today many major biopharma …
Continuous downstream bioprocessing for intensified manufacture of biopharmaceuticals and antibodies
Continuous production delivers higher productivity and better quality than traditional batch-
wise approaches. It intensifies production lowering capital cost and enables better control …
wise approaches. It intensifies production lowering capital cost and enables better control …
An NIR‐based PAT approach for real‐time control of loading in protein A chromatography in continuous manufacturing of monoclonal antibodies
Control of column loading in Protein A chromatography is a crucial part of development of
robust and flexible process platforms for continuous production of monoclonal antibody …
robust and flexible process platforms for continuous production of monoclonal antibody …
[HTML][HTML] Experimental characterization of axial dispersion in coiled flow inverters
D Rossi, L Gargiulo, G Valitov, A Gavriilidis… - … Research and Design, 2017 - Elsevier
Narrow residence time distributions (RTDs) are desirable in many chemical engineering
processes. However, when a system operates in the laminar flow regime, significant fluid …
processes. However, when a system operates in the laminar flow regime, significant fluid …
Continuous integrated antibody precipitation with two‐stage tangential flow microfiltration enables constant mass flow
D Burgstaller, A Jungbauer… - Biotechnology and …, 2019 - Wiley Online Library
Continuous precipitation is a new unit operation for the continuous capture of antibodies.
The capture step is based on continuous precipitation with PEG6000 and Zn++ in a tubular …
The capture step is based on continuous precipitation with PEG6000 and Zn++ in a tubular …
Precipitation as an enabling technology for the intensification of biopharmaceutical manufacture
M Martinez, M Spitali, EL Norrant, DG Bracewell - Trends in biotechnology, 2019 - cell.com
Advances in precipitation have demonstrated the capability of purifying therapeutic proteins
such as antibodies from biological sources in a scalable and cost-effective manner. We …
such as antibodies from biological sources in a scalable and cost-effective manner. We …